 Concord Medical Services Holdings Limited Concord Medical or the Company NYSE: CCM, a healthcare provider specializing in cancer care, research, education and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2019 the Annual Report with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medicals investor relations website at and on the SECs website at Shareholders may receive a hard copy of the Annual Report free of charge upon request. Requests should be submitted to 